Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- PHARM.ST
- Price
- -
- Stock movement down
- -0.11 (-16.17%)
- Company name
- Pharmiva AB
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Biotechnology
- Market cap
- 9.73M
- Ent value
- 8.71M
- Price/Sales
- 2.64
- Price/Book
- 0.63
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -60.14%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
PHARM.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 2.64 |
| Price to Book | 0.63 |
| EV to Sales | 2.36 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 17.38M |
| EPS (TTM) | -1.25 |
| FCF per share (TTM) | -1.11 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 3.68M |
| Gross profit (TTM) | 2.91M |
| Operating income (TTM) | -21.11M |
| Net income (TTM) | -21.72M |
| EPS (TTM) | -1.25 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 78.96% |
| Operating margin (TTM) | -573.15% |
| Profit margin (TTM) | -589.52% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 4.94M |
| Net receivables | 1.74M |
| Total current assets | 7.65M |
| Goodwill | 0.00 |
| Intangible assets | 11.70M |
| Property, plant and equipment | 25.00K |
| Total assets | 19.37M |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 3.92M |
| Total liabilities | 3.92M |
| Shareholder's equity | 15.45M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -19.34M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -19.34M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -140.53% |
| Return on Assets | -112.13% |
| Return on Invested Capital | -140.53% |
| Cash Return on Invested Capital | -125.18% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| PHARM.ST | S&P500 | |
| Current price drop from All-time high | -95.74% | -5.64% |
| Highest price drop | -95.74% | -56.47% |
| Date of highest drop | 17 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -61.05% | -11.07% |
| Avg time to new high | 111 days | 12 days |
| Max time to new high | 563 days | 1805 days |
COMPANY DETAILS
Marketcap
9.73M
Marketcap category
Small-cap
Description
Pharmiva AB (publ) engages in the research and development of medical products in Sweden. The company offers Vernivia, an over-the-counter vaginal mousse for the treatment of bacterial vaginosis. The company was incorporated in 2015 and is headquartered in Lund, Sweden.
Employees
5
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found